Recent advances in perioperative anesthetic management update on the role of vasopressin and its effects on outcomes

Current Pharmaceutical Design

Volumn 18, Issue 38, 2012, Pages 6308-6313

  Udeh, Chiedozie I ^a   Diaz Gomez J L ^a   Anthony, D ^a   Satyapriya, A ^a   Perez Protto, S ^a   Hata, J S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Critical care; Hypotension; Shock; Vasopressin

Indexed keywords

ADRENALIN; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VASOPRESSIN;

ANESTHESIA; CARDIOPULMONARY BYPASS; CIRCULATION; HEART ARREST; HEART FUNCTION; HUMAN; HYPOTENSION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEPTIC SHOCK; VASOPLEGIA;

ANESTHESIA; ANIMALS; ANTIDIURETIC AGENTS; CRITICAL CARE; HEART ARREST; HEMODYNAMICS; HUMANS; PERIOPERATIVE CARE; SHOCK; SHOCK, SEPTIC; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 84873959489     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212803832326     Document Type: Review

References (76)

1. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95(5): 1122-5.
2. Ganong WF. Central regulation of visceral function, in review of medical physiology. Norwalk, Appleton & Lange 1989; pp. 199-204.
3. Sladen R. Renal physiology, in anesthetic pharmacology: physiologic principles and clinical practice. Philadelphia: Churchill Livingstone 2004; pp. 339-54.
4. Holmes CL, Landry DW, Granton JT. Science review: Vasopressin and the cardiovascular system part 1--receptor physiology. Crit Care 2003; 7(6): 427-34.
5. Sharman A, James L. Vasopressin and its role in critical care. Continuing Education in Anaesthesia, Crit Care Pain 2008; 8(4): 134-7.
6. Brown D. Hypothalamic, pituitary and sex hormones, in clinical pharmacology. Edinburgh: Churchill Livingstone 2003; pp. 711-3.
7. Holmes CL, Landry DW, Granton JT. Science Review: Vasopressin and the cardiovascular system part 2-clinical physiology. Crit Care 2004; 8(1): 15-23.
8. Thibonnier M., Conarty DM, Preston JA, et al. Human vascular endothelial cells express oxytocin receptors. Endocrinology 1999; 140(3): 1301-9.
9. Holt NF, Haspel KL. Vasopressin: a review of therapeutic applications. J Cardiothorac Vasc Anesth 2010; 24(2): 330-47.
10. Rajani RR, Ball CG, Feliciano DV, et al. Vasopressin in hemorrhagic shock: review article. Am Surg 2009; 75(12): 1207-12.
11. rd, Segel LD. Direct cardiac effects of vasopressin and their reversal by a vascular antagonist. Am J Physiol 1986; 251(4 Pt 2): H734-41.
12. Khayyal MA, Eng C, Franzen D, et al. Effects of vasopressin on the coronary circulation: reserve and regulation during ischemia. Am J Physiol 1985; 248(4 Pt 2): H516-22.
13. Dunser MW, Hasibeder WR. Vasopressin in vasodilatory shock: ensure organ blood flow, but take care of the heart! Crit Care 2006; 10(6): 172.
14. Asfar P, Radermacher P. Vasopressin and ischaemic heart disease: more than coronary vasoconstriction? Crit Care 2009; 13(4): 169.
15. Vanhoutte PM, Katusic ZS, Shepherd JT. Vasopressin induces endothelium-dependent relaxations of cerebral and coronary, but not of systemic arteries. J Hypertens Suppl 1984; 2(3): S421-2.
16. Boyle, WA 3rd, Segel LD. Attenuation of vasopressin-mediated coronary constriction and myocardial depression in the hypoxic heart. Circ Res 1990; 66(3): 710-21.
17. Walker BR, Childs ME, Adams EM. Direct cardiac effects of vasopressin: role of V1-and V2-vasopressinergic receptors. Am J Physiol 1988; 255(2 Pt 2): H261-5.
18. Indrambarya T, Boyd JH, Wang Y, et al. Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice. Crit Care 2009; 13(3): R98.
19. Muller S, How OJ, Hermansen SE, et al. Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia. Crit Care 2008; 12(1): R20.
20. Morales DL, Gregg D, Helman DN, et al. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg 2000; 69(1): 102-6.
21. Argenziano M, Chen JM, Cullinane S, et al. Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation. J Heart Lung Transplant 1999; 18(8): 814-7.
22. Suojaranta-Ylinen RT, Vento AE, Patila T, et al. Vasopressin, when added to norepinephrine, was not associated with increased predicted mortality after cardiac surgery. Scand J Surg 2007; 96(4): 314-8.
23. Argenziano M, Choudhri AF, Oz MC, et al. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 1997; 96(9 Suppl): II-286-90.
24. Rosenfeldt FL, He GW, Buxton BF, et al. Pharmacology of coronary artery bypass grafts. Ann Thorac Surg 1999; 67(3): 878-88.
25. Jett GK, Arcidi JM, Jr, Dorsey LM, et al. Vasoactive drug effects on blood flow in internal mammary artery and saphenous vein grafts. J Thorac Cardiovasc Surg 1987; 94(1): 2-11.
26. Novella S, Martinez AC, Pagan RM, et al. Plasma levels and vascular effects of vasopressin in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg 2007; 32(1): 69-76.
27. Park SY, Kim DH, Kim JS, et al. Comparative effects of norepinephrine and vasopressin on internal thoracic arterial graft flow after off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg 2011; 141(1): 151-4.
28. Ryckwaert F, Virsolvy A, Fort A, et al. Terlipressin, a provasopressin drug exhibits direct vasoconstrictor properties: consequences on heart perfusion and performance. Crit Care Med 2009; 37(3): 876-81.
29. Bragadottir G, Redfors B, Nygren A, et al. Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients. Acta Anaesthesiol Scand 2009; 53(8): 1052-9.
30. Nygren A, Thoren A, Ricksten SE. Vasopressin decreases intestinal mucosal perfusion: a clinical study on cardiac surgery patients in vasodilatory shock. Acta Anaesthesiol Scand 2009; 53(5): 581-8.
31. Jeon Y, Ryu JH, Lim YJ, et al. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients. Eur J Cardiothorac Surg 2006; 29(6): 952-6.
32. Evora PR, Pearson PJ, Schaff HV. Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide. Chest 1993; 103(4): 1241-5.
33. Lavigne D. Vasopressin and methylene blue: alternate therapies in vasodilatory shock. Semin Cardiothorac Vasc Anesth 2010; 14(3): 186-9.
34. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36(1): 296-327.
35. Holmes CL, Patel BM, Russell JA, et al. Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120(3): 989-1002.
36. Landry DW, Levin HR, Gallant EM, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997; 25(8): 1279-82.
37. Malay MB, Ashton RC, Jr., Landry DW, et al. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999; 47(4): 699-705.
38. Patel BM., Chittock DR, Russell JA, et al. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96(3): 576-82.
39. Tsuneyoshi I, Yamada H, Kakihana Y, et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29(3): 487-93.
40. Lauzier F, Levy B, Lamarre P, et al. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med 2006; 32(11): 1782-9.
41. Holmes CL. Is low-dose vasopressin the new reno-protective agent? Crit Care Med 2004; 32(9): 1972-4.
42. Dunser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 2003; 107(18): 2313-9.
43. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358(9): 877-87.
44. Stahl W, Bracht H, Radermacher P, et al. Year in review 2009: Critical Care-shock. Crit Care 2010; 14(6): 239.
45. Keyes R, Brindley PG. Best evidence in critical care medicine. Vasopressin in septic shock: pressing questions remain. Can J Anaesth 2009; 56(1): 80-2.
46. Russell JA, Walley KR, Gordon AC, et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med 2009; 37(3): 811-8.
47. Gordon AC, Russell JA, Walley KR, et al. The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med 2010; 36(1): 83-91.
48. Holmes CL, Walley KR, Chittock DR, et al. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 2001; 27(8): 1416-21.
49. Kampmeier TG, Rehberg S, Westphal M, et al. Vasopressin in sepsis and septic shock. Minerva Anestesiol 2010; 76(10): 844-50.
50. Lange M, Van Aken H, Westphal M, et al. Role of vasopressinergic V1 receptor agonists in the treatment of perioperative catecholamine-refractory arterial hypotension. Best Pract Res Clin Anaesthesiol 2008; 22(2): 369-81.
51. Argenziano M., Chen JM, Choudhri AF, et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 1998; 116(6): 973-80.
52. Rosenman DJ, McDonald FS, Ebbert JO, et al. Clinical consequences of withholding versus administering renin-angiotensinaldosterone system antagonists in the preoperative period. J Hosp Med 2008; 3(4): 319-25.
53. Hasija S, Makhija N, Choudhury M, et al. Prophylactic vasopressin in patients receiving the angiotensin-converting enzyme inhibitor ramipril undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2010; 24(2): 230-8.
54. Papadopoulos G, Sintou E, Siminelakis S, et al. Perioperative infusion of low-dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study. J Cardiothorac Surg 2010; 5: 17.
55. Mets B, Michler RE, Delphin ED, et al. Refractory vasodilation after cardiopulmonary bypass for heart transplantation in recipients on combined amiodarone and angiotensin-converting enzyme inhibitor therapy: a role for vasopressin administration. J Cardiothorac Vasc Anesth 1998; 12(3): 326-9.
56. Morales DL, Garrido MJ, Madigan JD, et al. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg 2003; 75(3): 926-30.
57. Paradis NA, Wenzel V, Southall J. Pressor drugs in the treatment of cardiac arrest. Cardiol Clin 2002; 20(1): 61-78, viii.
58. Lindner KH, Strohmenger HU, Ensinger H, et al. Stress hormone response during and after cardiopulmonary resuscitation. Anesthesiology 1992; 77(4): 662-8.
59. Lindner KH, Prengel AW, Pfenninger EG, et al. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation 1995; 91(1): 215-21.
60. Prengel AW, Lindner KH, Keller A. Cerebral oxygenation during cardiopulmonary resuscitation with epinephrine and vasopressin in pigs. Stroke 1996; 27(7): 1241-8.
61. Wenzel V, Lindner KH, Prengel AW, et al. Vasopressin improves vital organ blood flow after prolonged cardiac arrest with postcountershock pulseless electrical activity in pigs. Crit Care Med 1999; 27(3): 486-92.
62. Wenzel V, Lindner KH, Krismer AC, et al. Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs. J Am Coll Cardiol 2000; 35(2): 527-33.
63. Wenzel V, Lindner KH, Mayer H, et al. Vasopressin combined with nitroglycerin increases endocardial perfusion during cardiopulmonary resuscitation in pigs. Resuscitation 1998; 38(1): 13-7.
64. Lindner KH, Prengel AW, Brinkmann A, et al. Vasopressin administration in refractory cardiac arrest. Ann Intern Med 1996; 124(12): 1061-4.
65. Lindner KH, Dirks B, Strohmenger HU, et al. Randomised comparison of epinephrine and vasopressin in patients with out-ofhospital ventricular fibrillation. Lancet 1997; 349(9051): 535-7.
66. Kornberger E, Prengel AW, Krismer A, et al. Vasopressinmediated adrenocorticotropin release increases plasma cortisol concentrations during cardiopulmonary resuscitation. Crit Care Med 2000; 28(10): 3517-21.
67. Onuma T. Changes in the beta-receptor density and its responsiveness to beta-agonist in rabbit myocardium during hemorrhagic shock. Masui 1994; 43(6): 840-7.
68. McGillivray-Anderson KM, Faber JE. Effect of acidosis on contraction of microvascular smooth muscle by alpha 1-and alpha 2-adrenoceptors. Implications for neural and metabolic regulation. Circ Res 1990; 66(6): 1643-57.
69. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 6: advanced cardiovascular life support: 7D: the tachycardia algorithms. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Circulation 2000; 102(8 Suppl): I158-65.
70. Babar SI, Berg RA, Hilwig RW, et al. Vasopressin versus epinephrine during cardiopulmonary resuscitation: a randomized swine outcome study. Resuscitation 1999; 41(2): 185-92.
71. Wenzel V, Krismer AC, Arntz HR, et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 2004; 350(2): 105-13.
72. Mayr VD, Wenzel V, Voelckel WG, et al. Developing a vasopressor combination in a pig model of adult asphyxial cardiac arrest. Circulation 2001; 104(14): 1651-6.
73. Aung K, Htay T. Vasopressin for cardiac arrest: a systematic review and meta-analysis. Arch Intern Med 2005; 165(1): 17-24.
74. Gueugniaud PY, David JS, Chanzy E, et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med 2008; 359(1): 21-30.
75. Mentzelopoulos SD, Zakynthinos SG, Tzoufi M, et al. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest. Arch Intern Med 2009; 169(1): 15-24.
76. Field JM, Hazinski MF, Sayre MR, et al. Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122(18 Suppl 3): S640-56.